抗真菌剤の世界市場レポート 2024年

真菌感染症の流行増加は、抗真菌剤市場の成長を促進すると予想されます。SARS、ジカウイルス、エボラ出血熱、COVID-19などのさまざまな疾患により、世界中で感染症が増加し、世界の疾病負担の増大に寄与しています。世界保健機関（WHO）によると、2022年、COVID-19パンデミックの際、入院患者の真菌感染が大幅に増加しました。さらに、英国の週刊科学誌『ネイチャー』に掲載された2022年の論文では、中国武漢の集中治療室でCOVID-19患者の侵襲性カンジダ感染が急増したことが報告されています。さらに、パンデミックの第2波の間、インドでは2021年5月から8月にかけてCOVID-19に関連したムコルミコーシスの症例が47,500例以上報告されました。したがって、真菌感染症の罹患率の増加は、予測期間において抗真菌剤市場の原動力になると予想されます。

医療インフラの拡大が抗真菌剤市場の成長を牽引すると予想されます。医療インフラには、医療サービスの提供を促進する物理的・組織的構造、施設、システムが含まれます。真菌感染症の効果的な管理に必要不可欠な施設、システム、リソースが含まれます。例えば、2023年5月、英国の政府機関である国家統計局によると、2022年の英国の医療支出は約3,477億4,000万米ドルに達し、前年比0.7％の名目増加を反映しています。このような医療インフラへの投資は、今後の抗真菌剤市場の成長を促進する上で重要な役割を果たすと予想されます。

2023年の抗真菌剤市場における薬剤の最大地域は北米でした。中東は抗真菌剤市場で最も急成長する地域と予想されます。抗真菌剤市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 抗真菌剤市場の特徴

第3章 抗真菌剤市場の動向と戦略

第4章 抗真菌剤市場-マクロ経済シナリオ

• 高インフレが抗真菌剤市場に与える影響
• ウクライナ・ロシア戦争が抗真菌剤市場に与える影響
• COVID-19による抗真菌剤市場への影響

第5章 世界の抗真菌剤市場規模と成長

• 世界の抗真菌剤市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の抗真菌剤の市場規模実績と成長、2018～2023年
• 世界の抗真菌剤市場規模と成長予測、2023年から2028年、2033年

第6章 抗真菌剤市場セグメンテーション

• 世界の抗真菌剤市場、薬剤タイプ別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• エキノカンジン
• アゾール
• ポリエン
• アリルアミン
• 世界の抗真菌剤市場、投与経路別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• 経口
• 非経口
• 局所
• 世界の抗真菌剤市場、治療適応別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• アスペルギルス症
• 皮膚糸状菌症
• カンジダ症
• その他の治療適応
• 世界の抗真菌剤市場、エンドユーザー別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• 病院とクリニック
• 皮膚科クリニック
• 他のユーザー

第7章 抗真菌剤市場の地域および国分析

• 世界の抗真菌剤市場、地域別、実績および予測、2018～2023年、2023～2028年、2033年
• 世界の抗真菌剤市場、国別、実績および予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋の抗真菌剤市場

第9章 中国の抗真菌剤市場

第10章 インドの抗真菌剤市場

第11章 日本の抗真菌剤市場

第12章 オーストラリアの抗真菌剤市場

第13章 インドネシアの抗真菌剤市場

第14章 韓国の抗真菌剤市場

第15章 西欧の抗真菌剤市場

第16章 英国の抗真菌剤市場

第17章 ドイツの抗真菌剤市場

第18章 フランスの抗真菌剤市場

第19章 イタリアの抗真菌剤市場

第20章 スペインの抗真菌剤市場

第21章 東欧の抗真菌剤市場

第22章 ロシアの抗真菌剤市場

第23章 北米の抗真菌剤市場

第24章 米国の抗真菌剤市場

第25章 カナダの抗真菌剤市場

第26章 南米の抗真菌剤市場

第27章 ブラジルの抗真菌剤市場

第28章 中東の抗真菌剤市場

第29章 アフリカの抗真菌剤市場

第30章 抗真菌剤市場の競合情勢と企業プロファイル

• 抗真菌剤市場の競合情勢
• 抗真菌剤市場の企業プロファイル
  • Pfizer Inc.
  • Novartis International AG
  • Merck &Co. Inc.
  • Bayer AG
  • Abbott Laboratories

第31章 世界の抗真菌剤市場の競合ベンチマーキング

第32章 世界の抗真菌剤市場の競合ダッシュボード

第33章 抗真菌剤市場における主要な合併と買収

第34章 抗真菌剤市場の将来展望と可能性分析

第35章 付録

“Antifungals Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antifungals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antifungals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The antifungals market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Type: Echinocandins; Azoles; Polyenes; Allylamines
• 2) By Route of Administration: Oral; Parenteral; Topical
• 3) By End users: Hospitals & Clinics; Dermatology clinics; Other Users

Sub-Segments

• By Therapeutic Indications: Aspergillosis; Dermatophytosis; Candidiasis; Other Therapeutic Indications
• Companies Mentioned: Pfizer Inc.; Novartis International AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Antifungal drugs are pharmaceuticals designed to detect and eradicate fungal pathogens, particularly in conditions arising from unsanitary environments. These medications, also referred to as antimycotic drugs, serve to treat and prevent fungal infections like athlete's foot, ringworm, candidiasis (thrush), and more severe systemic conditions such as cryptococcal meningitis.

The primary categories of antifungal drugs include echinocandins, azoles, polyenes, and allylamines. Echinocandins represent a novel class of antifungal medications that operate by specifically inhibiting the formation of 1,3-D-glucan, a crucial component of the fungal cell wall. Antifungals can be administered through various routes, including oral, parenteral, and topical methods, and they cater to therapeutic indications such as aspergillosis, dermatophytosis, candidiasis, among others. These drugs find applications in various sectors, including hospitals and clinics, dermatology clinics, and other user groups.

The antifungals market research report is one of a series of new reports from The Business Research Company that provides antifungals market statistics, including antifungals industry global market size, regional shares, competitors with antifungals market share, detailed antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the antifungals industry. This antifungals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antifungals market size has grown strongly in recent years. It will grow from $24.48 billion in 2023 to $26.9 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed during the historical period can be attributed to several key factors, including the prevalence of fungal diseases, the presence of an aging population, the development of healthcare infrastructure, and increased awareness and education.

The antifungals market size is expected to see strong growth in the next few years. It will grow to $38.66 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to various factors, including the emergence of new fungal strains, regulatory approvals for antifungal drugs, global health concerns, rising healthcare expenditure, and heightened patient education and awareness. Additionally, significant trends in this forecast period encompass increased focus on research and development, the proliferation of telemedicine and e-health solutions, advancements in the development of antifungal drugs, and a growing number of collaborations and partnerships in the industry.

The rising prevalence of fungal infections is expected to drive the growth of the antifungals market. Various diseases such as SARS, Zika virus, Ebola, and COVID-19 have led to an increasing number of infections worldwide, contributing to a higher global disease burden. According to the World Health Organization (WHO), in 2022, during the COVID-19 pandemic, there was a significant increase in fungal infections among hospitalized patients. Additionally, a 2022 article published in the British weekly scientific journal Nature reported a surge in invasive Candida infections in COVID-19 patients in the intensive care units of Wuhan, China. Furthermore, during the second wave of the pandemic, India reported over 47,500 cases of COVID-19-associated mucormycosis between May and August 2021. Therefore, the growing incidence of fungal infections is expected to be a driving force behind the antifungals market in the forecast period.

The expansion of healthcare infrastructure is expected to drive the growth of the antifungals market. Healthcare infrastructure includes the physical and organizational structures, facilities, and systems that facilitate the delivery of healthcare services. It encompasses the essential facilities, systems, and resources required for the effective management of fungal infections. For example, in May 2023, according to the Office for National Statistics, a UK-based government body, the healthcare spending in the UK reached approximately $347.74 billion in 2022, reflecting a nominal increase of 0.7% compared to the previous year. This investment in healthcare infrastructure is anticipated to play a significant role in propelling the growth of the antifungals market in the future.

Antifungal drug manufacturers are increasingly employing price skimming strategies for their branded products. The research, development, and production of branded drugs often involve substantial investments. Consequently, these companies launch their branded drugs at premium prices and use various pricing tactics to maintain competitiveness at these elevated price levels. Price skimming is a pricing approach in which a company starts with a high initial price and subsequently reduces it to appeal to more price-sensitive customers. This strategy is particularly useful when introducing a new product to the market, aiming to maximize profits. Manufacturers and marketers of branded antifungal drugs are encouraged to consider the adoption of the price skimming strategy for their products. By setting initial high prices, they can recoup the significant costs associated with drug development and manufacturing while gradually making the product more accessible to a broader customer base.

Drug developers and manufacturers in the anti-infective drugs market are increasingly focusing on expanding their operations by strengthening various departments, including research and development, marketing, and manufacturing. They are achieving this through collaborative efforts and strategic partnerships with other companies and research institutes. These collaborations enable them to diversify their product portfolios and stay competitive in the market while increasing their revenues. Therefore, companies operating in the anti-infective drugs market should seriously consider the potential benefits of strategic collaborations. Such partnerships can help them broaden their product offerings, enhance their market presence, and ultimately drive higher revenues, ensuring their continued competitiveness in the market.

Major companies in the antifungals market are actively involved in product innovation to enhance their profitability. One notable innovation is the development of Supra Bioavailable Itraconazole, an advanced formulation of the antifungal medication itraconazole aimed at improving its bioavailability and efficacy in the treatment of fungal infections. For example, in June 2022, Apex Labs, an India-based pharmaceutical company, introduced Supra Bioavailable Itraconazole in 65 and 130 mg capsules. These capsules deliver a higher proportion (90 percent) of the active medication to the body's biological system, necessitating lower dosages. This reduction in inter-individual variability holds the potential for enhanced effectiveness in the treatment of fungal infections. Such innovations play a crucial role in strengthening a company's position and profitability in the antifungals market.

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline PLC, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc., Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company PLC, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

North America was the largest region in the drugs for antifungals market in 2023. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The antifungal market consists of sales of clotrimazole, miconazole, and ketoconazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Antifungals Market Characteristics

3. Antifungals Market Trends And Strategies

4. Antifungals Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Antifungals Market Size and Growth

• 5.1. Global Antifungals Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Antifungals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Antifungals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antifungals Market Segmentation

• 6.1. Global Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Echinocandins
• Azoles
• Polyenes
• Allylamines
• 6.2. Global Antifungals Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Topical
• 6.3. Global Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Aspergillosis
• Dermatophytosis
• Candidiasis
• Other Therapeutic Indications
• 6.4. Global Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals and Clinics
• Dermatology clinics
• Other Users

7. Antifungals Market Regional And Country Analysis

• 7.1. Global Antifungals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Antifungals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antifungals Market

• 8.1. Asia-Pacific Antifungals Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antifungals Market

• 9.1. China Antifungals Market Overview
• 9.2. China Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antifungals Market

• 10.1. India Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antifungals Market

• 11.1. Japan Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.2. Japan Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antifungals Market

• 12.1. Australia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antifungals Market

• 13.1. Indonesia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antifungals Market

• 14.1. South Korea Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.2. South Korea Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antifungals Market

• 15.1. Western Europe Antifungals Market Overview
• 15.2. Western Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antifungals Market

• 16.1. UK Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antifungals Market

• 17.1. Germany Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antifungals Market

• 18.5. France Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antifungals Market

• 19.9. Italy Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antifungals Market

• 20.13. Spain Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antifungals Market

• 21.1. Eastern Europe Antifungals Market Overview
• 21.2. Eastern Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antifungals Market

• 22.1. Russia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antifungals Market

• 23.1. North America Antifungals Market Overview
• 23.2. North America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antifungals Market

• 24.1. USA Antifungals Market Overview
• 24.2. USA Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antifungals Market

• 25.1. Canada Antifungals Market Overview
• 25.2. Canada Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antifungals Market

• 26.1. South America Antifungals Market Overview
• 26.2. South America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antifungals Market

• 27.1. Brazil Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antifungals Market

• 28.1. Middle East Antifungals Market Overview
• 28.2. Middle East Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antifungals Market

• 29.1. Africa Antifungals Market Overview
• 29.2. Africa Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Antifungals Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antifungals Market Competitive Landscape And Company Profiles

• 30.1. Antifungals Market Competitive Landscape
• 30.2. Antifungals Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Novartis International AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Abbott Laboratories
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Antifungals Market Competitive Benchmarking

32. Global Antifungals Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Antifungals Market

34. Antifungals Market Future Outlook and Potential Analysis

• 34.1 Antifungals Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Antifungals Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Antifungals Market In 2028 - Growth Strategies
• 34.3.1 Market Trend Based Strategies
• 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer